Abstract
We describe a highly variable clinical presentation of cerebellar ataxia in two sisters. The younger sister demonstrates early onset rapidly progressive cerebellar ataxia accompanied by motor and nonmotor cerebellar features, as well as cognitive decline and psychiatric problems. Mitochondrial respiratory chain enzyme analysis in muscle showed a decrease in complex I + III. Progressive cerebellar atrophy was demonstrated on serial brain MR imaging. Coenzyme Q10 (CoQ10) supplementation, started at the age of 5 years, led to a significant improvement in motor and cognitive abilities with partial amelioration of the cerebellar signs. Discontinuation of this treatment resulted in worsening of the ataxia, cognitive decline, and severe depression.
The older sister, who is 32 years old, has nonprogressive dysarthria and clumsiness from the age of 10 years and MRI reveals cerebellar atrophy.
Exome sequencing identified compound heterozygosity for a known (p. Thr584delACC (c.1750_1752delACC)) and a novel (p.P502R) mutation in the ACDK3 gene.
Conclusions: Patients with primary CoQ10 deficiency due to ADCK3 mutations can demonstrate a wide spectrum of clinical presentations even in the same family. It is difficult to diagnose CoQ10 deficiency based solely on the clinical presentation.
Exome sequencing can provide the molecular diagnosis but since it is expensive and not readily available, we recommend a trial of CoQ10 treatment in patients with ataxia and cerebellar atrophy even before confirmation of the molecular diagnosis.
Competing interests: None declared
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Maawali A, Blaser S, Yoon G (2012) Diagnostic approach to childhood-onset cerebellar atrophy: a 10-year retrospective study of 300 patients. J Child Neurol 27:1121–1132
Artuch R, Brea-Calvo G, Briones P, Aracil A, Galva´n A, Espinos C, Corral J, Volpini V, Ribes A, Andreu AL, Palau F, Sa´nchez-Alca´zar JA, Navas P, Pineda M (2006) Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci 246:153–158
Aure K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombe‘s A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727–729
Bird TD (2012) Hereditary ataxia overview. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) GeneReviews™ [Internet]. University of Washington, Seattle, 28 Oct 1993–1998 [updated 2012 Nov 01]
Boddaert N, Desguerre I, Bahi-Buisson N et al (2010) Posterior fossa imaging in 158 children with ataxia. J Neuroradiol 37(4):220–230
Emmanuele V, López LC, Berardo A, Naini A, Tadesse S, Wen B, D’Agostino E, Solomon M, DiMauro S, Quinzii C, Hirano M (2012) Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol 69(8):978–983
Finsterer J (2009) Mitochondrial ataxias. Can J Neurol Sci 36:543–553
Gerards M, van den Bosch B, Calis C et al (2010) Nonsense mutations in ADCK3cause progressive cerebellar ataxia and atrophy. Mitochondrion 10:510–515
Horvath R, Czermin B, Gulati S et al (2012) Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3. J Neurol Neurosurg Psychiatry 83:174–178
Lagier-Tourenne C, Tazir M (2008) Lo’pez LC, et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661–672
Lamperti C, Naini A, Hirano M et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206–1208
Mollet J, Delahodde A, Serre V et al (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623–630
Montero R, Pineda M, Aracil A, Vilaseca MA, Briones P, Sánchez-Alcázar JA, Navas P, Artuch R (2007) Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency. Cerebellum 6(2):118–122
Pineda M, Montero R, Aracil A et al (2010) Coenzyme Q(10)-responsive ataxia: 2-yeartreatment follow-up. Mov Disord 25(9):1262–1268
Quinzii CM, Hirano M (2011) Primary and secondary CoQ10 deficiencies in humans. Biofactors 37:361–365
Ramaekers VT, Heimann G, Reul J et al (1997) Genetic disorders and cerebellar structural abnormalities in childhood. Brain 120(Pt 10):1739–1751
Steinlin M, Blaser S, Boltshauser E (1998) Cerebellar involvement in metabolic disorders: a pattern-recognition approach. Neuroradiology 40(6):347–354
Terracciano A, Renaldo F, Zanni G et al (2012) The use of muscle biopsy in the diagnosis of undefined ataxia with cerebellar atrophy in children. Eur J Paediatr Neurol 16(3):248–256
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Nicole Wolf, MD PhD
Rights and permissions
Copyright information
© 2013 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Blumkin, L., Leshinsky-Silver, E., Zerem, A., Yosovich, K., Lerman-Sagie, T., Lev, D. (2013). Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 12. JIMD Reports, vol 12. Springer, Cham. https://doi.org/10.1007/8904_2013_251
Download citation
DOI: https://doi.org/10.1007/8904_2013_251
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-03460-7
Online ISBN: 978-3-319-03461-4
eBook Packages: MedicineMedicine (R0)